Doctolib was last valued at $6.4B (post-money). It comes from the $550M 2022 equity + debt round of Mar 2022. The company is private, so there is no listed share price.
1 valuation. The latest, $6.4B post-money, was set by the 2022 equity + debt round in Mar 2022.
A private valuation is the price agreed in one transaction. The Doctolib valuation of $6.4B is a post-money figure from the 2022 equity + debt round dated 15 Mar 2022 — the whole company measured after the $550M raised in that round was already inside it. Subtract the round and the pre-money view of the same deal is $5.8B .
The valuation holds until the next priced round or secondary sale. A private company founded in 2013 with roughly 1,722 people has no daily price and no order book between rounds.
The last valuation is $6.4B.
Lead investors for each round are in the funding timeline.
The closest healthtech / medical appointment booking peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
